Cardiology
News
VIDEO: Exploring SYMPLICITY’s failure, Part 2
Conference Coverage
Apixaban provides larger medical cost savings than other NOACs
Major finding: Using apixaban instead of warfarin for stroke prevention in AF would result in an estimated medical cost savings of $1,245 per...
News
One in four patients with hypertension nonadherent to therapy
Major finding: A urine test available to commercial labs showed that 25% of patients were totally (10.1%) or partially (14.9%) nonadherent to...
News
Too much or too little sodium may boost cardiovascular risk
Major finding: Compared with patients with low sodium intake (less than 2,645 mg/day) or high sodium intake (greater than 4,945 mg/day), patients...
PURLs
Should you consider antibiotics for exacerbations of mild COPD?
Yes. Guidelines recommend antibiotics for exacerbations in patients with moderate to severe COPD, and evidence shows they may be effective for...
Clinical Inquiries
How do hydrochlorothiazide and chlorthalidone compare for treating hypertension?
EVIDENCE-BASED ANSWER: Both medications reduce theincidence of cardiovascular events in patients with hypertension, but chlorthalidone may confer...
Conference Coverage
Evolocumab betters ezetimibe for lowering LDL in statin-intolerant patients
Major finding: Statin-intolerant patients with hypercholesterolemia experienced mean 53%-56% reductions in LDL cholesterol in response to 12 weeks...
Conference Coverage
VIDEO: Novel drug misses mark for MI prevention, but shows promise
Conference Coverage
Quality gap in atrial fibrillation care significant
Major finding: A total of 36% of patients with a CHADS2 score of 5, and 41.2% with a score of 6 left the hospital without medications to prevent...
Conference Coverage
No improvements in left ventricular function with metformin after myocardial infarction
Major finding: Treatment with metformin after STEMI had no significant impact on LVEF or on the incidence of major cardiac events in nondiabetic...
Conference Coverage
Neither perioperative aspirin nor clonidine prevents MI
Major finding: The primary outcome of death or MI occurred in 7% of the aspirin group and 7.1% of the placebo group, a nonsignificant difference;...